Insider plans sale of 3,052 OCUL shares

A shareholder of OCUL filed a notice of proposed sale under Rule 144 for 3,052 shares of common stock, with an aggregate market value of $27,903.83.

Accepted by SEC EDGAR 02/02/2026 - 04:28 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

A shareholder of OCUL filed a notice of proposed sale under Rule 144 for 3,052 shares of common stock, with an aggregate market value of $27,903.83. The shares were acquired on 01/30/2026 through restricted stock vesting under a registered plan.

The planned sale is to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services on the NASDAQ, with an approximate sale date of 02/02/2026. OCUL had 213,047,472 shares of common stock outstanding at the time referenced.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the OCUL Form 144 filing disclose?

The Form 144 filing discloses a proposed sale of 3,052 OCUL common shares by a shareholder. The shares, valued at $27,903.83 in total, are planned to be sold on NASDAQ through Morgan Stanley Smith Barney LLC Executive Financial Services.

How many OCUL shares are planned to be sold and at what value?

The filing indicates a planned sale of 3,052 OCUL common shares with an aggregate market value of $27,903.83. This figure is based on market pricing at the time of the notice and reflects the total value of the proposed transaction.

How were the OCUL shares being sold under Form 144 acquired?

The OCUL shares were acquired on 01/30/2026 through restricted stock vesting under a registered plan. The issuer granted 3,052 common shares, which vested and became eligible for sale, prompting the shareholder to file the Rule 144 notice.

When is the OCUL shareholder planning to sell the shares?

The Form 144 states an approximate sale date of 02/02/2026. This indicates the shareholder’s intention to begin selling 3,052 OCUL common shares around that date, subject to market conditions and compliance with Rule 144 requirements.

Which broker and exchange are involved in the OCUL share sale?

The proposed sale will be executed through Morgan Stanley Smith Barney LLC Executive Financial Services, located in New York. The 3,052 OCUL common shares are planned to be sold on the NASDAQ exchange, as specified in the Form 144 filing.

How many OCUL shares were outstanding at the time of the notice?

The filing reports that 213,047,472 OCUL common shares were outstanding. This number provides context for the planned sale of 3,052 shares, showing the broader share base against which this individual transaction occurs.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002073994
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	OCULAR THERAPEUTIX, INC.
SEC File Number	001-36554
Address of Issuer	15 Crosby Drive Bedford MASSACHUSETTS 01730
Phone	781-357-4000
Name of Person for Whose Account the Securities are To Be Sold	STEVE MEYERS
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	3052	27903.83	213047472	02/02/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/30/2026	Restricted stock vesting under a registered plan	Issuer			3052	01/30/2026	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	02/02/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Steve Meyers
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)